This Phase 2 trial aims to assess the safety, tolerability, and foralumab’s effect on microglial activation in patients with na-SPMS. Intranasal foralumab offers a novel approach to potentially ...

This research presents a review of circulating cell-free DNA essential role in the early diagnosis and immunotherapy of pancreatic cancer. The detection methods of cfDNA, its potential as a diagnostic ...

Although EBV is treatable, it can trigger an array of diseases including autoimmune diseases. One major risk factor of multiple sclerosis (MS) includes EBV infection. MS is a chronic inflammatory ...

Among trial finishers, omalizumab and oral immunotherapy offered similar protection against food allergies, and some people ...

State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center, ...

A generation ago, a diagnosis of multiple sclerosis often meant a steady decline in quality of life. The autoimmune disease, which affects nearly a million people in the U.S., causes the immune ...

Get Instant Summarized Text (Gist) An immunotherapy previously ineffective against prostate cancer shows potential when combined with a synergistic treatment. By inhibiting PIM1 kinase in tumor ...

The final, formatted version of the article will be published soon. The intricate interaction between skeletal muscle biomechanics, the tumor microenvironment, and immunotherapy constitutes a pivotal ...

These findings have implications for leveraging ERVs for cancer immunotherapy. Cell. 2025 Feb 25 [Epub ahead of print] Qinqin Jiang, David A Braun, Karl R Clauser, Vijyendra Ramesh, Nitin H Shirole, ...

However, injectable immunotherapy hasn't worked for food allergies ... peanut-containing candies (such as M&Ms), and peanut-containing puffs (like Bamba) from the U.S. and the European Union ...

A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025 ...